Long non-coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Knockdown of Long Noncoding RNA LUCAT1 Inhibits Cell Viability and Invasion by Regulating miR-375 in Glioma

(2018) Yan-Sheng Gao et al.   ONCOLOGY RESEARCH

Long noncoding RNA TSLNC8 is a tumor suppressor that inactivates the interleukin-6/STAT3 signaling pathway

(2017) Jiwei Zhang et al.   HEPATOLOGY

Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis

(2017) Dan Li et al.   HEPATOLOGY

Profiling, clinicopathological correlation and functional validation of specific long non-coding RNAs for hepatocellular carcinoma

(2017) Jian Yao et al.   Molecular Cancer

Mechanism of plasmin generation by S100A10

(2017) Victoria Miller et al.   THROMBOSIS AND HAEMOSTASIS

Long non-coding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and regulates cell proliferation via epigenetically repressing p21 and p57 expression

(2017) Yue Sun et al.   Oncotarget

Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis

(2017) Yan Chen et al.   Cancer Medicine

Long-term efficacy and downstream mechanism of anti-annexinA2 monoclonal antibody (anti-ANX A2 mAb) in a pre-clinical model of aggressive human breast cancer

(2016) Mahesh C. Sharma et al.   CANCER LETTERS

ANXA2 enhances the progression of hepatocellular carcinoma via remodeling the cell motility associated structures

(2016) Hongyan Shi et al.   MICRON

Molecular Pathogenesis of Hepatocellular Carcinoma

(2016) Daniel Wai-Hung Ho et al.   Liver Cancer

RNAi-mediated silencing of Anxa2 inhibits breast cancer cell proliferation by downregulating cyclin D1 in STAT3-dependent pathway

(2015) Fei Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

The story of HCC in NAFLD: from epidemiology, across pathogenesis, to prevention and treatment

(2015) Cristina Margini et al.   LIVER INTERNATIONAL

ERG Oncoprotein Inhibits ANXA2 Expression and Function in Prostate Cancer

(2014) Nicholas B. Griner et al.   MOLECULAR CANCER RESEARCH

Characterization of a Novel Long Noncoding RNA, SCAL1, Induced by Cigarette Smoke and Elevated in Lung Cancer Cell Lines

(2013) Philip Thai et al.   AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY

Annexin A2 Heterotetramer: Structure and Function

(2013) Alamelu Bharadwaj et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Alendronate promotes plasmin-mediated MMP-9 inactivation by exposing cryptic plasmin degradation sites within the MMP-9 catalytic domain

(2012) Antonietta R. Farina et al.   FEBS LETTERS

Surgical Treatment for Hepatocellular Carcinoma

(2011) T. Takayama   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Annexin 2 Regulates Endothelial Morphogenesis by Controlling AKT Activation and Junctional Integrity

(2010) Shih-Chi Su et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Feedback Regulation of Endothelial Cell Surface Plasmin Generation by PKC-dependent Phosphorylation of Annexin A2

(2010) Kai-Li He et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

ECRG2 regulates ECM degradation and uPAR/FPRL1 pathway contributing cell invasion/migration

(2009) Xiaolong Cheng et al.   CANCER LETTERS

Annexin II promotes invasion and migration of human hepatocellular carcinoma cellsin vitrovia its interaction with HAb18G/CD147

(2009) Pu Zhao et al.   CANCER SCIENCE

Anxa2 Plays a Critical Role in Enhanced Invasiveness of the Multidrug Resistant Human Breast Cancer Cells

(2009) Fei Zhang et al.   JOURNAL OF PROTEOME RESEARCH

Annexin A2 Regulates the Levels of Plasmin, S100A10 and Fascin in L5178Y Cells

(2008) Yingchun Hou et al.   CANCER INVESTIGATION

Endothelial Cell Annexin A2 Regulates Polyubiquitination and Degradation of Its Binding Partner S100A10/p11

(2008) Kai-Li He et al.   JOURNAL OF BIOLOGICAL CHEMISTRY